Literature DB >> 21118898

Ftx is a non-coding RNA which affects Xist expression and chromatin structure within the X-inactivation center region.

Corinne Chureau1, Sophie Chantalat, Antonio Romito, Angélique Galvani, Laurent Duret, Philip Avner, Claire Rougeulle.   

Abstract

X chromosome inactivation (XCI) is an essential epigenetic process which involves several non-coding RNAs (ncRNAs), including Xist, the master regulator of X-inactivation initiation. Xist is flanked in its 5' region by a large heterochromatic hotspot, which contains several transcription units including a gene of unknown function, Ftx (five prime to Xist). In this article, we describe the characterization and functional analysis of murine Ftx. We present evidence that Ftx produces a conserved functional long ncRNA, and additionally hosts microRNAs (miR) in its introns. Strikingly, Ftx partially escapes X-inactivation and is upregulated specifically in female ES cells at the onset of X-inactivation, an expression profile which closely follows that of Xist. We generated Ftx null ES cells to address the function of this gene. In these cells, only local changes in chromatin marks are detected within the hotspot, indicating that Ftx is not involved in the global maintenance of the heterochromatic structure of this region. The Ftx mutation, however, results in widespread alteration of transcript levels within the X-inactivation center (Xic) and particularly important decreases in Xist RNA levels, which were correlated with increased DNA methylation at the Xist CpG island. Altogether our results indicate that Ftx is a positive regulator of Xist and lead us to propose that Ftx is a novel ncRNA involved in XCI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118898     DOI: 10.1093/hmg/ddq516

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  102 in total

Review 1.  Gracefully ageing at 50, X-chromosome inactivation becomes a paradigm for RNA and chromatin control.

Authors:  Jeannie T Lee
Journal:  Nat Rev Mol Cell Biol       Date:  2011-11-23       Impact factor: 94.444

Review 2.  Interplay of chromatin modifications and non-coding RNAs in the heart.

Authors:  Prabhu Mathiyalagan; Samuel T Keating; Xiao-Jun Du; Assam El-Osta
Journal:  Epigenetics       Date:  2013-10-10       Impact factor: 4.528

3.  Clustered transcripts that escape X inactivation at mouse XqD.

Authors:  Alexandra M Lopes; Sarah E Arnold-Croop; António Amorim; Laura Carrel
Journal:  Mamm Genome       Date:  2011-07-19       Impact factor: 2.957

Review 4.  Regulation of X-chromosome inactivation by the X-inactivation centre.

Authors:  Sandrine Augui; Elphège P Nora; Edith Heard
Journal:  Nat Rev Genet       Date:  2011-06       Impact factor: 53.242

Review 5.  Dosage compensation in mammals.

Authors:  Neil Brockdorff; Bryan M Turner
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-03-02       Impact factor: 10.005

6.  Unusual semi-extractability as a hallmark of nuclear body-associated architectural noncoding RNAs.

Authors:  Takeshi Chujo; Tomohiro Yamazaki; Tetsuya Kawaguchi; Satoshi Kurosaka; Toru Takumi; Shinichi Nakagawa; Tetsuro Hirose
Journal:  EMBO J       Date:  2017-04-12       Impact factor: 11.598

Review 7.  The X chromosome in space.

Authors:  Teddy Jégu; Eric Aeby; Jeannie T Lee
Journal:  Nat Rev Genet       Date:  2017-05-08       Impact factor: 53.242

8.  Coupling of X-chromosome reactivation with the pluripotent stem cell state.

Authors:  Bernhard Payer; Jeannie T Lee
Journal:  RNA Biol       Date:  2014-08-19       Impact factor: 4.652

Review 9.  Long nonoding RNAs in the X-inactivation center.

Authors:  Emily Maclary; Michael Hinten; Clair Harris; Sundeep Kalantry
Journal:  Chromosome Res       Date:  2013-12       Impact factor: 5.239

10.  Nonrandom X chromosome inactivation is influenced by multiple regions on the murine X chromosome.

Authors:  Joanne L Thorvaldsen; Christopher Krapp; Huntington F Willard; Marisa S Bartolomei
Journal:  Genetics       Date:  2012-08-10       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.